Gaurav Goparaju
Stock Analyst at Berenberg
(0.19)
# 3,273
Out of 4,479 analysts
8
Total ratings
11.11%
Success rate
-18.02%
Average return
Main Sectors:
Top Industries:
8 Stocks
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TWST Twist Bioscience | Initiates: Buy | $27 | $47.32 | -42.94% | 1 | Sep 27, 2023 | |
| EXAI Exscientia | Initiates: Buy | $13 | $5.10 | +154.90% | 1 | Jul 21, 2023 | |
| MORF Morphic Holding | Initiates: Buy | $75 | $31.28 | +139.77% | 1 | Jul 21, 2023 | |
| DNA Ginkgo Bioworks Holdings | Initiates: Buy | $6 | $0.35 | +1,631.60% | 1 | Nov 29, 2022 | |
| ME 23andMe Holding Co. | Initiates: Buy | $7 | $0.39 | +1,686.63% | 1 | Nov 29, 2022 | |
| CERT Certara | Initiates: Buy | $23 | $13.66 | +68.37% | 1 | Sep 8, 2022 | |
| ABSI Absci | Initiates: Buy | $28 | $2.97 | +842.76% | 1 | Feb 1, 2022 | |
| RLAY Relay Therapeutics | Initiates: Buy | $45 | $6.47 | +595.52% | 1 | Feb 1, 2022 |
Twist Bioscience
Sep 27, 2023
Initiates: Buy
Price Target: $27
Current: $47.32
Upside: -42.94%
Exscientia
Jul 21, 2023
Initiates: Buy
Price Target: $13
Current: $5.10
Upside: +154.90%
Morphic Holding
Jul 21, 2023
Initiates: Buy
Price Target: $75
Current: $31.28
Upside: +139.77%
Ginkgo Bioworks Holdings
Nov 29, 2022
Initiates: Buy
Price Target: $6
Current: $0.35
Upside: +1,631.60%
23andMe Holding Co.
Nov 29, 2022
Initiates: Buy
Price Target: $7
Current: $0.39
Upside: +1,686.63%
Certara
Sep 8, 2022
Initiates: Buy
Price Target: $23
Current: $13.66
Upside: +68.37%
Absci
Feb 1, 2022
Initiates: Buy
Price Target: $28
Current: $2.97
Upside: +842.76%
Relay Therapeutics
Feb 1, 2022
Initiates: Buy
Price Target: $45
Current: $6.47
Upside: +595.52%